Home › Clifton, NJ
Clinical trials in Clifton, NJ
319 clinical studies are recruiting at sites in and around Clifton (within about 30 miles).
Studies for healthy volunteers in Clifton — 10 studies
Studies by condition
- Non-Small Cell Lung Cancer23 studies
- Multiple Myeloma15 studies
- Cancer (all types)13 studies
- Prostate Cancer12 studies
- Acute Myeloid Leukemia11 studies
- Ovarian Cancer11 studies
- Metastatic Cancer11 studies
- Breast Cancer11 studies
- Colorectal Cancer9 studies
- Lung Cancer9 studies
- Heart Failure9 studies
- Leukemia8 studies
- Blood Cancers8 studies
- Head and Neck Squamous Cell Carcinoma8 studies
- Endometrial Cancer7 studies
- Triple-Negative Breast Cancer7 studies
- Myelodysplastic Syndromes7 studies
- Burkitt Lymphoma7 studies
- Follicular Lymphoma7 studies
- Chronic Lymphocytic Leukemia7 studies
- Non-Hodgkin Lymphoma7 studies
- Kidney Cancer (Renal Cell Carcinoma)6 studies
- Lymphoma6 studies
- Diffuse Large B-Cell Lymphoma6 studies
- Small Cell Lung Cancer5 studies
- Acute Biphenotypic Leukemia5 studies
- Melanoma5 studies
- Acute Lymphoblastic Leukemia5 studies
- Seizures5 studies
- Urothelial (Transitional Cell) Carcinoma4 studies
- Liver Cancer (Hepatocellular Carcinoma)4 studies
- Neuroblastoma4 studies
- Osteosarcoma4 studies
- Epilepsy4 studies
- Immune System and Disorders4 studies
- Speech Sound Disorder4 studies
- Cardiovascular Disease4 studies
- Alzheimer's Disease4 studies
- Germ Cell and Embryonal Cancer3 studies
- Cervical Cancer3 studies
- Blood Disorders3 studies
- Neoplasms by Histologic Type3 studies
- Colon Cancer3 studies
- Pancreatic Cancer3 studies
- Multiple Sclerosis3 studies
- Castration-Resistant Prostatic Cancer3 studies
- Primitive Neuroectodermal Tumors3 studies
- Autism Spectrum Disorder3 studies
- Ischemic Stroke3 studies
- B-Cell Leukemia3 studies
- Mantle Cell Lymphoma3 studies
- B-Cell Lymphoma3 studies
- Atrial Fibrillation3 studies
- Bladder Cancer3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.